Benlysta News
Most Popular Benlysta Story
HGS shares surge on Glaxo buyout reports
Shares of Human Genome Sciences hit $19.20--a seven-year high--after reports surfaced yesterday that the market has been buzzing about an upcoming buyout offer from GlaxoSmithKline. The Telegraph lit... Read more...
Latest Headlines
- November 30, 2009
- November 2, 2009
- October 20, 2009
- August 26, 2009
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
